Psychedelic pharma lists on ASX

By Megan Brodie 2 months ago | In Companies, Industry
  • 2 months ago
CEO Jason Carroll and Non-Executive Director Chris Ntoumenopoulos ring the bell to signify Tryp's listing on the ASX

31 May 2024 A Perth-based pharma company developing therapeutics based on the active ingredient in…

This is subscriber-only content. Please login to continue reading.